#soul machine - if we had a couple of similar ‘high brand’ clients (wow like Pfizer) then 2c a bargain.
unfortunately we do not - having high level well recognised customers equals validation of the product.
creeping revenues may sustain the company and its workforce but larger clients and tangible revenues will sustain shareholders. Nothing less relegates us to ongoing speculation.
The periodic takeover talk IMHO is way too premature. GLTAH 2024
#soul machine - if we had a couple of similar ‘high brand’...
Add UNT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.7¢ |
Change
-0.001(5.56%) |
Mkt cap ! $20.88M | |||
| Open | High | Low | Value | Volume |
| 1.8¢ | 1.8¢ | 1.7¢ | $81.93K | 4.680M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 1167646 | 1.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.8¢ | 320000 | 2 |
View Market Depth
| Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
| UNT (ASX) Chart |